These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 19937689)
21. Non-invasive diagnosis and monitoring of liver fibrosis and cirrhosis. Denzer UW; Lüth S Best Pract Res Clin Gastroenterol; 2009; 23(3):453-60. PubMed ID: 19505671 [TBL] [Abstract][Full Text] [Related]
22. Predictors of steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease. Pagadala M; Zein CO; McCullough AJ Clin Liver Dis; 2009 Nov; 13(4):591-606. PubMed ID: 19818307 [TBL] [Abstract][Full Text] [Related]
23. Assessment by Fibroscan of fibrosis in nonalcoholic fatty liver disease: XL versus M probe? Petta S; Craxì A Hepatology; 2012 Apr; 55(4):1309; author reply 1309-10. PubMed ID: 22307871 [No Abstract] [Full Text] [Related]
24. Myths and mysteries about staging hepatic fibrosis by fibroscan. Vuppalanchi R; Sanyal AJ Clin Gastroenterol Hepatol; 2015 Apr; 13(4):780-2. PubMed ID: 25451885 [No Abstract] [Full Text] [Related]
25. IS ARFI A USEFUL TOOL FOR NON-INVASIVE EVALUATION OF LIVER STIFFNESS IN NONALCOHOLIC FATTY LIVER DISEASE AND HEPATITIS C? Ozturker C; Karagoz E; Sildiroglu HO Arq Gastroenterol; 2016; 53(3):212. PubMed ID: 27438430 [No Abstract] [Full Text] [Related]
26. [Hemorrhagic thrombocytemia in association with portal liver cirrhosis]. Snagovskaia EA; Korostylev VI Vrach Delo; 1976 Mar; (3):56-9. PubMed ID: 944970 [No Abstract] [Full Text] [Related]
27. Is past exposure to hepatitis A protective against progressive fibrosis in non-alcoholic fatty liver disease? de Silva AP; Kasturiratne A; Liyanage DL; Karunanayaka TK; de S Hewavisenthi SJ; Dassanayake AS; Farrell GC; de Silva HJ Liver Int; 2008 Jan; 28(1):147-9. PubMed ID: 18173565 [No Abstract] [Full Text] [Related]
29. Hepatic cirrhosis secondary to nonalcoholic fatty liver disease in a 12-year-old girl with morbid obesity. Sharma A; Freese DK; Chandan V; Zarroug AE; Swain JM; Kumar S Clin Pediatr (Phila); 2014 Jan; 53(1):86-8. PubMed ID: 23564302 [No Abstract] [Full Text] [Related]
30. Intermittent disconjugate gaze: a novel finding in nonalcoholic steatohepatitis and cryptogenic cirrhosis. Al-Osaimi AM; Berg CL; Caldwell SH Hepatology; 2005 Apr; 41(4):943. PubMed ID: 15791607 [No Abstract] [Full Text] [Related]
31. Acoustic radiation force-based shear stiffness and non-invasive panels of tests in Japanese patients with nonalcoholic fatty liver disease. Yoneda M; Imajo K; Kirikoshi H; Nakajima A J Hepatol; 2012 Mar; 56(3):740-1. PubMed ID: 21884671 [No Abstract] [Full Text] [Related]
32. When liver stiffness is not so straight forward and Fibroscan not so simple. Lee AU J Gastroenterol Hepatol; 2009 Jun; 24(6):934-6. PubMed ID: 19638074 [No Abstract] [Full Text] [Related]
33. The use of acoustic radiation force-based shear stiffness in non-alcoholic fatty liver disease. Cross TJ J Hepatol; 2012 Apr; 56(4):995; author reply 996. PubMed ID: 21946021 [No Abstract] [Full Text] [Related]
34. [Prospect of liver fibrosis]. Jia JD Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):5-6. PubMed ID: 19391279 [No Abstract] [Full Text] [Related]
35. Nonlinear distribution of adiponectin in patients with nonalcoholic fatty liver disease limits its use in linear regression analysis. Polyzos SA; Kountouras J; Zavos C J Clin Gastroenterol; 2010 Mar; 44(3):229-30; author reply 230-1. PubMed ID: 19770674 [No Abstract] [Full Text] [Related]
36. Liver biopsy: the best, not the gold standard. Bedossa P; Carrat F J Hepatol; 2009 Jan; 50(1):1-3. PubMed ID: 19017551 [No Abstract] [Full Text] [Related]